|
DGAP-Ad-hoc: Alzchem Group AG / Key word(s): Forecast/Change in Forecast Alzchem Group AG increases sales forecast for the fiscal year 2022 Trostberg, 22 April 2022 - Against the background of the current market developments, Alzchem Group AG is increasing its sales forecast for the fiscal year 2022. The company now expects to generate "strongly to particularly strongly increasing" consolidated sales of up to EUR 520 million (previously: up to EUR 480 million). The other forecasts for the fiscal year 2022 made in the consolidated financial statements as of December 31, 2021 remain unchanged. The increase in the forecast ceiling for consolidated sales is mainly the result of developments on the raw material and energy markets. Here the company is forced in almost all business areas to pass on the higher purchase prices to the market. By contrast, the company believes that the pure volume growth will develop in line with the previous forecast. The successful passing on of the price increases will have no impact on the other forecast key figures. In particular, a potentially stronger growth in EBITDA is currently not expected due to the extremely volatile purchasing markets and the contract-related time lag in passing on the cost increases. The possible further effects of the war in Ukraine and the strains on global supply chains are not included in the forecast and cannot be reliably foreseen by the company at present.
22-Apr-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Alzchem Group AG |
| Dr.-Albert-Frank-Str. 32 | |
| 83308 Trostberg | |
| Germany | |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 1333427 |
| End of Announcement | DGAP News Service |
|
|
1333427 22-Apr-2022 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
